Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Jun;87(6):2169–2177. doi: 10.1172/JCI115250

Sp alpha V/41: a common spectrin polymorphism at the alpha IV-alpha V domain junction. Relevance to the expression level of hereditary elliptocytosis due to alpha-spectrin variants located in trans.

N Alloisio 1, L Morlé 1, J Maréchal 1, A F Roux 1, M T Ducluzeau 1, D Guetarni 1, B Pothier 1, F Baklouti 1, A Ghanem 1, R Kastally 1, et al.
PMCID: PMC296976  PMID: 2040699

Abstract

Spectrin alpha-chain mutants associated with hereditary elliptocytosis are highly variable in their level of expression. It has been assumed that the degree of elliptocytosis can be increased when the spectrin alpha chain, encoded by the alpha gene in trans to the variant, is expressed at a low level. We now provide strong evidence for the existence of low-level expression of spectrin alpha chains. This condition is referred to as the alpha V/41 polymorphism. It has been observed in 15 different families or individuals of French, North African, and African ancestry in which seven distinct elliptocytogenic alpha-spectrin variants were co-inherited. Whenever the alpha V/41 polymorphism was present, the severity of the biochemical, morphological, and, sometimes, the clinical phenotype of elliptocytosis was increased. The alpha V/41 polymorphism was also frequently encountered among 36 unrelated control subjects in the heterozygous or homozygous states, and was entirely asymptomatic in both cases. The main biochemical feature was an increased susceptibility to proteolysis of the alpha IV-alpha V domain junction. Alteration of the facing beta IV domain of spectrin was demonstrated by in vitro spectrin dimer reconstitution experiments. It appears that the alpha V/41 polymorphism is often required for alpha-spectrin elliptocytogenic variants to become manifest in the heterozygous state. Thus, alpha-spectrin-related elliptocytosis may be viewed as a bifactorial condition.

Full text

PDF
2169

Images in this article

2171Image
on p.2171
2171Image
on p.2171
2174Image
on p.2174
2175Image
on p.2175
2175Image
on p.2175

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alloisio N., Guetarni D., Morlé L., Pothier B., Ducluzeau M. T., Soun A., Colonna P., Clerc M., Philippe N., Delaunay J. Sp alpha I/65 hereditary elliptocytosis in North Africa. Am J Hematol. 1986 Oct;23(2):113–122. doi: 10.1002/ajh.2830230205. [DOI] [PubMed] [Google Scholar]
  2. Alloisio N., Morlé L., Pothier B., Roux A. F., Maréchal J., Ducluzeau M. T., Benhadji-Zouaoui Z., Delaunay J. Spectrin Oran (alpha II/21), a new spectrin variant concerning the alpha II domain and causing severe elliptocytosis in the homozygous state. Blood. 1988 Apr;71(4):1039–1047. [PubMed] [Google Scholar]
  3. Becker P. S., Morrow J. S., Lux S. E. Abnormal oxidant sensitivity and beta-chain structure of spectrin in hereditary spherocytosis associated with defective spectrin-protein 4.1 binding. J Clin Invest. 1987 Aug;80(2):557–565. doi: 10.1172/JCI113104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coetzer T., Lawler J., Prchal J. T., Palek J. Molecular determinants of clinical expression of hereditary elliptocytosis and pyropoikilocytosis. Blood. 1987 Sep;70(3):766–772. [PubMed] [Google Scholar]
  5. Coetzer T., Palek J., Lawler J., Liu S. C., Jarolim P., Lahav M., Prchal J. T., Wang W., Alter B. P., Schewitz G. Structural and functional heterogeneity of alpha spectrin mutations involving the spectrin heterodimer self-association site: relationships to hematologic expression of homozygous hereditary elliptocytosis and hereditary pyropoikilocytosis. Blood. 1990 Jun 1;75(11):2235–2244. [PubMed] [Google Scholar]
  6. Delaunay J., Alloisio N., Morlé L., Pothier B. The red cell skeleton and its genetic disorders. Mol Aspects Med. 1990;11(3):161–241. doi: 10.1016/0098-2997(90)90001-i. [DOI] [PubMed] [Google Scholar]
  7. Garbarz M., Lecomte M. C., Féo C., Devaux I., Picat C., Lefebvre C., Galibert F., Gautero H., Bournier O., Galand C. Hereditary pyropoikilocytosis and elliptocytosis in a white French family with the spectrin alpha I/74 variant related to a CGT to CAT codon change (Arg to His) at position 22 of the spectrin alpha I domain. Blood. 1990 Apr 15;75(8):1691–1698. [PubMed] [Google Scholar]
  8. Guetarni D., Roux A. F., Alloisio N., Morlé F., Ducluzeau M. T., Forget B. G., Colonna P., Delaunay J., Godet J. Evidence that expression of Sp alpha I/65 hereditary elliptocytosis is compounded by a genetic factor that is linked to the homologous alpha-spectrin allele. Hum Genet. 1990 Oct;85(6):627–630. doi: 10.1007/BF00193587. [DOI] [PubMed] [Google Scholar]
  9. Hanspal M., Palek J. Synthesis and assembly of membrane skeletal proteins in mammalian red cell precursors. J Cell Biol. 1987 Sep;105(3):1417–1424. doi: 10.1083/jcb.105.3.1417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hoffman N., Stanislovitis P., Watkins P. C., Klinger K. W., Linnenbach A. J., Forget B. G. Three RFLPs are detected by an alpha spectrin genomic clone. Nucleic Acids Res. 1987 Jun 11;15(11):4696–4696. doi: 10.1093/nar/15.11.4696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Huebner K., Palumbo A. P., Isobe M., Kozak C. A., Monaco S., Rovera G., Croce C. M., Curtis P. J. The alpha-spectrin gene is on chromosome 1 in mouse and man. Proc Natl Acad Sci U S A. 1985 Jun;82(11):3790–3793. doi: 10.1073/pnas.82.11.3790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Knowles W. J., Bologna M. L., Chasis J. A., Marchesi S. L., Marchesi V. T. Common structural polymorphisms in human erythrocyte spectrin. J Clin Invest. 1984 Apr;73(4):973–979. doi: 10.1172/JCI111322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lane P. A., Shew R. L., Iarocci T. A., Mohandas N., Hays T., Mentzer W. C. Unique alpha-spectrin mutant in a kindred with common hereditary elliptocytosis. J Clin Invest. 1987 Mar;79(3):989–996. doi: 10.1172/JCI112911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lawler J., Coetzer T. L., Mankad V. N., Moore R. B., Prchal J. T., Palek J. Spectrin-alpha I/61: a new structural variant of alpha-spectrin in a double-heterozygous form of hereditary pyropoikilocytosis. Blood. 1988 Oct;72(4):1412–1415. [PubMed] [Google Scholar]
  15. Lazarides E. From genes to structural morphogenesis: the genesis and epigenesis of a red blood cell. Cell. 1987 Nov 6;51(3):345–356. doi: 10.1016/0092-8674(87)90631-3. [DOI] [PubMed] [Google Scholar]
  16. Morlé L., Alloisio N., Ducluzeau M. T., Pothier B., Blibech R., Kastally R., Delaunay J. Spectrin Tunis (alpha I/78): a new alpha I variant that causes asymptomatic hereditary elliptocytosis in the heterozygous state. Blood. 1988 Feb;71(2):508–511. [PubMed] [Google Scholar]
  17. Morlé L., Morlé F., Roux A. F., Godet J., Forget B. G., Denoroy L., Garbarz M., Dhermy D., Kastally R., Delaunay J. Spectrin Tunis (Sp alpha I/78), an elliptocytogenic variant, is due to the CGG----TGG codon change (Arg----Trp) at position 35 of the alpha I domain. Blood. 1989 Aug 1;74(2):828–832. [PubMed] [Google Scholar]
  18. Morlé L., Roux A. F., Alloisio N., Pothier B., Starck J., Denoroy L., Morlé F., Rudigoz R. C., Forget B. G., Delaunay J. Two elliptocytogenic alpha I/74 variants of the spectrin alpha I domain. Spectrin Culoz (GGT----GTT; alpha I 40 Gly----Val) and spectrin Lyon (CTT----TTT; alpha I 43 Leu---Phe). J Clin Invest. 1990 Aug;86(2):548–554. doi: 10.1172/JCI114743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Palek J. Hereditary elliptocytosis and related disorders. Clin Haematol. 1985 Feb;14(1):45–87. [PubMed] [Google Scholar]
  20. Palek J., Lambert S. Genetics of the red cell membrane skeleton. Semin Hematol. 1990 Oct;27(4):290–332. [PubMed] [Google Scholar]
  21. Pothier B., Alloisio N., Maréchal J., Morlé L., Ducluzeau M. T., Caldani C., Philippe N., Delaunay J. Assignment of Sp alpha I/74 hereditary elliptocytosis to the alpha- or beta-chain of spectrin through in vitro dimer reconstitution. Blood. 1990 May 15;75(10):2061–2069. [PubMed] [Google Scholar]
  22. Pothier B., Alloisio N., Morlé L., Maréchal J., Barthélemy H., Ducluzeau M. T., Dorier A., Delaunay J. Two distinct variants of erythrocyte spectrin beta IV domain. Hum Genet. 1989 Nov;83(4):373–376. doi: 10.1007/BF00291384. [DOI] [PubMed] [Google Scholar]
  23. Roux A. F., Morlé F., Guetarni D., Colonna P., Sahr K., Forget B. G., Delaunay J., Godet J. Molecular basis of Sp alpha I/65 hereditary elliptocytosis in North Africa: insertion of a TTG triplet between codons 147 and 149 in the alpha-spectrin gene from five unrelated families. Blood. 1989 Jun;73(8):2196–2201. [PubMed] [Google Scholar]
  24. Sahr K. E., Tobe T., Scarpa A., Laughinghouse K., Marchesi S. L., Agre P., Linnenbach A. J., Marchesi V. T., Forget B. G. Sequence and exon-intron organization of the DNA encoding the alpha I domain of human spectrin. Application to the study of mutations causing hereditary elliptocytosis. J Clin Invest. 1989 Oct;84(4):1243–1252. doi: 10.1172/JCI114291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Speicher D. W., Morrow J. S., Knowles W. J., Marchesi V. T. A structural model of human erythrocyte spectrin. Alignment of chemical and functional domains. J Biol Chem. 1982 Aug 10;257(15):9093–9101. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES